Countable Labs

Use Countable Labs PCR assay services to develop assays for gene targets. Services ensure optimized primers and conditions for reliable quantification.

Discover PCR applications with Countable PCR — rare mutation detection, orthogonal gene validation, and cell & gene therapy development.

Verified assays for Countable PCR include performance data, protocols, and oligo sequences for quick setup.

Browse Countable Labs products, kits, and accessories for direct, single-molecule gene target counting with precision PCR.

Ancora presents webinar data on BCR::ABL1 precision and KMT2A fusion coverage from limited specimens.

Countable Labs provides research insights, updates, and perspectives on PCR and genomics.

Countable Labs launches Countable PCR RNA Module, a one-step workflow for RNA quantification that merges reverse transcription, PCR, and counting in a single tube.

Countable Labs launches Countable PCR to finally quantify rare events, even from limited samples, in a familiar PCR workflow.

A high-sensitivity digital counting assay using deep sampling to enable accurate rare molecule detection for KIT, overcoming input and partitioning limitations of conventional dPCR systems.

Countable Labs shares news, product innovations, and milestones in genomics and PCR technology.

Countable PCR overcomes dPCR’s partition limits and narrow range with a 6-log dynamic range and 30M compartments.

Countable PCR directly counts genetic targets, avoiding thresholding, Poisson correction, and variable results.

Countable Labs develops breakthrough genomics tools with unmatched sensitivity and precision to advance biomarker analysis and gene therapeutics.

Countable Labs offers information about Countable PCR and its genomics tools.

The Make It Count Grant application requires a research proposal submission for consideration.

Countable PCR counts DNA molecules with single-molecule precision, delivering high sensitivity and accuracy.

Countable Labs’ Legal Center provides policies and information about their operations.

The Make It Count Grant outlines terms, applicant eligibility, award details, and recipient obligations.

Countable Labs introduces **Ancora assays** for oncology, using its **Countable PCR technology** to provide precise, unambiguous molecular testing for hematologic malignancies. The assays overcome limitations of traditional PCR methods by delivering absolute quantification of samples. The company’s entry marks a new benchmark in clinical molecular diagnostics for cancer care.

Oct 2026selectscience.netNews article

Countable Labs and Promega partner to combine Promega’s nucleic acid extraction tools with Countable Labs’ Countable PCR technology. The collaboration enables an integrated workflow for biological sample preparation and rare variant detection in research. The joint offering aims to enhance accuracy and streamline processes for researchers.

Jun 2026BioSpaceNews article

Countable Labs secures $26 million in funding to advance its 10-color PCR-based solutions for cell and gene therapy, minimal residual disease (MRD) testing, biomarker validation, and vaccine quality control. The round, led by ARCH Venture Partners with F-Prime Capital and Primer Ventures, will also drive global commercial growth. The company develops specialized diagnostic tools for precision medicine applications.

May 2026Analysis & Separations from Technology NetworksNews article

Countable Labs demonstrates how its Countable PCR technology enables precise single-molecule quantification in cell and gene therapy development. The company highlights its utility at the American Society of Gene and Cell Therapy (ASGCT) annual meeting through posters and presentations. This approach aims to fill key measurement gaps in therapeutic dosing and quality control for biopharma researchers.

May 2026BioSpaceNews article